FDA Adverse Event Injury Summary report: N

ENDOVIVE TWO-PORT TTP JEJUNAL FEEDING TUBE CAP

MDR report key: 1934119 · Received December 21, 2010

Report

Report Number
3005099803-2010-05181
Event Type
Injury
Date Received
December 21, 2010
Date of Event
November 18, 2010
Report Date
November 30, 2010
Manufacturer
BOSTON SCIENTIFIC - SPENCER
Product Code
KNT
PMA / PMN Number
K081739
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SE
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE COMPLAINANT WAS UNABLE TO PROVIDE THE SUSPECT DEVICE LOT NUMBER; THEREFORE, THE LOT EXPIRATION AND DEVICE MANUFACTURE DATES ARE UNKNOWN. (B)(4) - J-TUBE EXCHANGE. (B)(4) - THE REPORTED EVENT OF PHYTOBEZOAR ON DISTAL LOOP OF J-TUBE. THE COMPLAINANT INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A TWO PORT THROUGH THE PEG JEJUNAL FEEDING TUBE (J-TUBE) WAS BEING USED FOR THE PURPOSE OF ADMINISTERING MEDICATION FOR THE ADVANCED STAGE PARKINSON'S DISEASE. THE J-TUBE WAS PLACED ON (B)(6) 2010. ACCORDING TO THE COMPLAINANT, ON (B)(6) 2010, THE PATIENT PRESENTED WITH PAIN AND A PHYTOBEZOAR ON THE DISTAL LOOP OF THE J-TUBE. THE PHYTOBEZOAR WAS REMOVED BY MEANS OF AN ESOPHAGOGASTRODUODENOSCOPY. THE PROCEDURE WAS COMPLETED WITH A NEW TWO PORT THROUGH THE PEG JEJUNAL FEEDING TUBE (J-TUBE). ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION REGARDING THE CIRCUMSTANCES SURROUNDING THIS EVENT HAVE BEEN UNSUCCESSFUL TO DATE. SHOULD ADDITIONAL RELEVANT DETAILS BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOVIVE TWO-PORT TTP JEJUNAL FEEDING TUBE CAP TUBES, GASTROINTESTINAL (AND ACCESSORIES) KNT BOSTON SCIENTIFIC - SPENCER UNK443

Patients

Seq Age Sex Outcome Treatment
1 Other DUODOPA